Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Varicella: complications and costs.

S R Preblud

    Pediatrics
    |October 1, 1986
    PubMed
    Summary

    A new varicella (chickenpox) vaccine shows promise for high-risk children and could save money if used in a universal childhood vaccination program. This vaccine may reduce costs by 66% for the general population.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    A measles outbreak at a college with a prematriculation immunization requirement.

    American journal of public health·1991
    Same author

    Measles among the Amish: a comparative study of measles severity in primary and secondary cases in households.

    The Journal of infectious diseases·1991
    Same author

    Measles antibody: reevaluation of protective titers.

    The Journal of infectious diseases·1990
    Same author

    A school-based measles outbreak: the effect of a selective revaccination policy and risk factors for vaccine failure.

    American journal of epidemiology·1990
    Same author

    Duration of live measles vaccine-induced immunity.

    The Pediatric infectious disease journal·1990
    Same author

    Evidence against increasing rubella seronegativity among adolescent girls.

    American journal of public health·1990

    Area of Science:

    • Immunology
    • Vaccinology
    • Public Health

    Background:

    • Varicella (chickenpox) is typically a mild childhood illness but poses severe risks to high-risk groups, like leukemic children.
    • Concerns regarding severe varicella complications in vulnerable populations have driven vaccine development.

    Purpose of the Study:

    • To evaluate the potential benefits of a live, attenuated varicella vaccine.
    • To assess the economic impact of a childhood varicella vaccination program.

    Main Methods:

    • Clinical trials of a live, attenuated varicella vaccine.
    • Economic modeling to estimate cost savings from a vaccination program.

    Main Results:

    • The varicella vaccine has shown favorable results in initial testing.
    • A childhood vaccination program could reduce varicella-related costs by 66%, yielding a $7 return for every $1 spent.

    Conclusions:

    • A varicella vaccine may soon be available for high-risk individuals.
    • Widespread childhood varicella vaccination could offer significant economic benefits and reduce disease burden.

    Related Experiment Videos